Skip to main content
Top
Literature
1.
go back to reference Wasson S, Folzenlogen D (2006) Concurrent occurrence of Sweet’s syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses. Clin Rheumatol 25:268–272PubMedCrossRef Wasson S, Folzenlogen D (2006) Concurrent occurrence of Sweet’s syndrome and erythema nodosum: an overlap in the spectrum of reactive dermatoses. Clin Rheumatol 25:268–272PubMedCrossRef
2.
go back to reference Winkelmann RK, Förstrom L (1975) New observations in the histopathology of erythema nodosum. J Invest Dermatol 65:441–445PubMedCrossRef Winkelmann RK, Förstrom L (1975) New observations in the histopathology of erythema nodosum. J Invest Dermatol 65:441–445PubMedCrossRef
3.
go back to reference Förstrom L, Winkelmann RK (1977) Acute panniculitis: a clinical and histopathologic study of 34 cases. Arch Dermatol 113:909–917PubMedCrossRef Förstrom L, Winkelmann RK (1977) Acute panniculitis: a clinical and histopathologic study of 34 cases. Arch Dermatol 113:909–917PubMedCrossRef
4.
go back to reference Thurber S, Kohler S (2006) Histopathological spectrum of erythema nodosum. J Cutan Pathol 33:18–26PubMedCrossRef Thurber S, Kohler S (2006) Histopathological spectrum of erythema nodosum. J Cutan Pathol 33:18–26PubMedCrossRef
5.
go back to reference Ginarte M, Garcia Doval I, Toribio J (1997) Síndrome de Sweet: estudio de 16 casos. Med Clin (Barc) 109:588–591 Ginarte M, Garcia Doval I, Toribio J (1997) Síndrome de Sweet: estudio de 16 casos. Med Clin (Barc) 109:588–591
6.
go back to reference Noguera X, Blaustein A, Moragas JM (1983) Un caso especial de síndrome de Sweet. Actas Dermosifiliogr 74:352 Noguera X, Blaustein A, Moragas JM (1983) Un caso especial de síndrome de Sweet. Actas Dermosifiliogr 74:352
7.
go back to reference Ginarte M, Toribio J (2000) Association of Sweet syndrome and erythema nodosum. Arch Dermatol 136:673–674PubMedCrossRef Ginarte M, Toribio J (2000) Association of Sweet syndrome and erythema nodosum. Arch Dermatol 136:673–674PubMedCrossRef
8.
go back to reference Vanaclocha F (1987) Eritema nudoso en el síndrome de Sweet. Actas Dermosifiliogr 78:55 Vanaclocha F (1987) Eritema nudoso en el síndrome de Sweet. Actas Dermosifiliogr 78:55
9.
go back to reference Sitjas D, Puig L, Cuatrecasas M, Moragas JM (1993) Acute febrile neutrophilic dermatosis (Sweet’s síndrome). Int J Dermatol 32:261–268PubMed Sitjas D, Puig L, Cuatrecasas M, Moragas JM (1993) Acute febrile neutrophilic dermatosis (Sweet’s síndrome). Int J Dermatol 32:261–268PubMed
10.
go back to reference Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D (2004) Neutrophilic panniculitis. J Am Acad Dermatol 50:280–285PubMedCrossRef Sutra-Loubet C, Carlotti A, Guillemette J, Wallach D (2004) Neutrophilic panniculitis. J Am Acad Dermatol 50:280–285PubMedCrossRef
11.
go back to reference Cohen PR (2005) Subcutaneous Sweet’s syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 52:927–928PubMedCrossRef Cohen PR (2005) Subcutaneous Sweet’s syndrome: a variant of acute febrile neutrophilic dermatosis that is included in the histopathologic differential diagnosis of neutrophilic panniculitis. J Am Acad Dermatol 52:927–928PubMedCrossRef
Metadata
Title
Sweet’s syndrome and erythema nodosum: two neutrophilic dermatoses?
Authors
M. Ginarte
J. Toribio
Publication date
01-07-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 7/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0564-7

Other articles of this Issue 7/2007

Clinical Rheumatology 7/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine